Press Releases

BOTHELL, WA - July 8, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, announced today that it will report the company's second quarter financial results on Monday, July 26, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on that day. The call will be broadcast live and can be accessed via Sonosite's website at www.sonosite.com/investorinformation/webcasts .

A replay of the audio webcast will be available beginning July 26, 2010 at 5:30 p.m. PT and can be accessed until August 9, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 2747293 is required to access the replay. Additionally, the call will be archived on Sonosite's website.

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA - June 29, 2010 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, said today that the Company plans to host its second annual Analyst Day. The meeting will be held on Thursday, August 12, 2010, at the company’s headquarters in Bothell.

The Analyst Day offers Sonosite institutional and mutual fund investors the opportunity to hear from key members of Sonosite’s leadership team and learn more about the Company’s recent acquisition of VisualSonics. The agenda will also include a Q&A session with select members of the executive team.

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound and industry leader in impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight ultrasound systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

BOTHELL, WA - June 11, 2010 – Sonosite, Inc. (NASDAQ: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced a stock repurchase program under which the company may purchase up to $50 million of its common stock over the next twelve months. Since February 2010, Sonosite has repurchased a total of approximately 3 million shares of its common stock through a modified “Dutch Auction” tender offer at a total cost of $88.8 million.

Sonosite may repurchase its common stock from time to time, in amounts, at prices and at such times as it deems appropriate, all subject to market conditions and other considerations. Sonosite may make repurchases in the open market, in privately negotiated transactions, accelerated repurchase programs or in structured share repurchase programs. The repurchases will be conducted in compliance with the SEC’s Rule 10b-18 and applicable legal requirements and shall be subject to market conditions and other factors.

The company also expects to establish Rule 10b5-1 trading plans from time to time to effect such purchases when appropriate. The program does not obligate Sonosite to acquire any particular amount of common stock and the program may be modified or suspended at any time at the company’s discretion. Any repurchases would be funded from available cash on hand. As of March 31, 2010, Sonosite had approximately $178 million in cash, cash equivalents and short-term investment securities.

About Sonosite, Inc.

Technology Leader in Ultra High-Frequency Micro-Ultrasound, Visualsonics, Generated $30M in Trailing Twelve Month Revenues and $5M of EBITDAS. Company is a Leader in the $350M Pre-Clinical Imaging Research Market Acquisition Stages Move of Ultra High-Frequency Ultrasound into Clinical Medicine Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern BOTHELL, WA - May 27, 2010 - Sonosite, Inc. (NASDAQ: SONO) , the world leader and specialist in bedside and point-of-care ultrasound, today announced that it has signed an agreement to acquire privately held Visualsonics , a Toronto-based company focused on ultra high-frequency micro-ultrasound technology. The aggregate transaction value will be approximately $71 million net of cash and debt. Visualsonics is the technology leader in real-time ultra high-frequency micro-ultrasound that presently serves the rapidly growing pre-clinical research market.